Misvik Biology

Misvik Biology Misvik Biology is a precision oncology company developing advanced technologies for therapy efficacy

FUNCTIONAL DRUG RESPONSE ASSESSMENT FOR PRECISION MEDICINE IN ONCOLOGY

Misvik Biology is a Finnish biotech company developing advanced diagnostic technologies for precision oncology and targeted therapies for rare cancers by ex vivo assessment of therapy efficacy using patient derived tumor and immune cells. The Company is driving clinical development of the TRIALTEST™ multiomics diagnostic test that predicts drug responses integrating knowledge of molecular pathology, single cell analyses and machine learning driven computational biology. NANOTOXICOLOGY RESEARCH

Misvik is also invested in the development of safety governance of Engineered NanoMaterials In Europe as part of several European research initiatives and the EU NanoSafety Cluster.

Osoite

KarjaKatu 35 B
Turku
20520

Nettisivu

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita Misvik Biology :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Oikopolut

Jaa

Kategoria